CommercialCoverageMedium impact
Home Cholesterol Monitors (CPB 0367, reviewed 2026-05-22)
Aetna·Cardiology, Internal Medicine, Family Medicine +2 more·Medical Policy
Effective date
May 22, 2026
We identified it
Aug 19, 2026
Summary
Aetna has classified home cholesterol monitors (including Cholestron and molecularly imprinted membrane modified gel colorimetric devices) as experimental, investigational, or unproven. HCPCS code A9279 is not covered for home cholesterol monitoring. Billing teams must deny or reject claims for these devices under Aetna plans, as clinical evidence does not support their use over periodic laboratory testing.
Action Required
Effective immediately (policy reviewed 2026-05-22): Billing team must update claim denial logic in billing software to automatically deny or reject HCPCS code A9279 when billed for home cholesterol monitoring indications. Add internal guidance document flagging A9279 as non-covered for Aetna plans. Providers and front-desk staff should be notified that patient requests for home cholesterol monitor coverage should be declined proactively. Claims submitted for A9279 under the listed ICD-10 codes (E71.30, E75.21-E75.22, E75.240-E75.249, E75.3, E75.6, E77.0-E77.9, E78.00-E78.9, E88.1-E88.2, E88.89, Z13.220) will be denied without exception. No prior authorization pathway exists; these are blanket non-covered services.